Ulcerative Colitis Treatment Market 2028 By Type, Medication | The Insight Partners

report image

Ulcerative Colitis Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Ulcerative Proctitis, Proctosigmoiditis, Left-Sided Colitis, Pancolitis or Universal Colitis, and Fulminant Colitis); Medication (5-Aminosalicylates, Steroids, Purine Analogs, Immunomodulators, and Biologics)

Report Code: TIPRE00019337 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming


Ulcerative colitis is a chronic idiopathic inflammatory gastrointestinal bowel disease (IBD) that damages the mucous membrane of the colon. It usually happens in individuals between 15 and 30 years of age. Ulcerative colitis along with Crohn's disease is one of two major forms of IBD. Ulcerative colitis typically requires only large intestines, as opposed to Crohn's disease, which can affect any part of the gastrointestinal tract.


Growing incidence of ulcerative colitis affecting millions of people worldwide is fueling the development of the world market for ulcerative colitis. In addition, there is a huge amount of R&D and funding from key players in creating innovative UC drugs and increasing the business development of government and non-governmental organisations in the field of biological science. However, prescription patents and tight regulatory controls on biosimilar approvals restrict the expansion of business. Failure to meet the UC criteria offers attractive growth prospects for the industry.


The "Ulcerative Colitis Treatment Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Ulcerative Colitis Treatment Market with detailed market segmentation by type, and medication. The Ulcerative Colitis Treatment Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Ulcerative Colitis Treatment Market and offers key trends and opportunities in the market.


The Ulcerative Colitis Treatment Market is segmented on the basis of type, medication. Based on type, the market is segmented as Ulcerative Proctitis, Proctosigmoiditis, Left-Sided Colitis, Pancolitis or Universal Colitis, and Fulminant Colitis. Based on medication, the market is segmented as 5-Aminosalicylates, Steroids, Purine Analogs, Immunomodulators, and Biologics.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Ulcerative Colitis Treatment Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Ulcerative Colitis Treatment Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Ulcerative Colitis Treatment Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Ulcerative Colitis Treatment Market in these regions.

Get more information on this report :


The report covers key developments in the Ulcerative Colitis Treatment Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Ulcerative Colitis Treatment Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Ulcerative Colitis Treatment Market in the global market. Below mentioned is the list of few companies engaged in the Ulcerative Colitis Treatment Market.

The report also includes the profiles of key players in Ulcerative Colitis Treatment Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Pfizer
  •   Novartis
  •   Roche
  •   Johnson and Johnson
  •   Bayer
  •   AbbVie
  •   Sanofi
  •   GSK
  •   AstraZeneca
  •   MSD

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Get more information on this report :

The List of Companies

1. Pfizer
2. Novartis
3. Roche
4. Johnson and Johnson
5. Bayer
6. AbbVie
7. Sanofi
8. GSK
9. AstraZeneca
10. MSD
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount